Carnell: Novo Nordisk data shows GLP-1s cut cardiovascular risk over 20%
Alex Carnell · GLP-1s, Peptides, and The Trillion-Dollar Health Revolution · Invest Like The Best · Apr 21, 2026 · at 31:04
Alex Carnell, founder of healthcare investment firm Braidwell, discusses trial evidence indicating GLP-1 medicines confer direct cardioprotective benefits independent of reduced body weight.
0:00 / 0:21exact quote · 21.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“We've got compelling data right now, ah, out of Novo Nordisk over the last year that basically shows that by taking GLP-I medicines, there is a, you know, north of 20% reduction in our risk of having a heart attack or a stroke. And what I thought was pretty profound about the full data that they put out is that that was independent of weight loss.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Alex Carnell
Carnell: Semaglutide and tirzepatide are clinically interchangeable despite distinct IP
“Our team's fundamental perspective is that they all achieve the same goals. They were just novel IP strategies to achieve those same goals. And I would say that they're all pretty much interchangeable.”
Carnell: Low-dose GLP-1s will likely be appropriate for almost everyone
“I would argue in the future, we could talk about why GLP-ONE's might be appropriate for just about everyone. That's because the reality of it is, as you go from your adolescence to your fifties and sixties, On average, people are going to pick up about five BM…”
Carnell: Scientists have already found medicines for most fatal diseases
“Is that incredible scientists have already cracked the code on most of the medicines we need to protect us from most of the diseases that will claim most of our lives.”
Carnell: Early proactive medicine will add a decade to expected lifespan
“Each of them has medicines available that if we could get on them early and be proactive about where we're going with our health, they will undoubtedly add an extra decade of life to our expected lifespan and have the potential to take curves that have been de…”
Carnell: No molecule is more important for longevity than GLP-1
“I fundamentally believe there's no molecule that's more important than GLP-one across that entire axis.”
Carnell: Upcoming data will show GLP-1s protect against addictive behaviors
“In terms of the addiction data that'll start coming out over the next year or so, you would lose that benefit. Like you would lose the, essentially the free gift of protecting yourself from being addicted to drugs, alcohol, or gambling. And that comes from the…”